|
|
|
Insider
Information: |
Spiegelman Daniel K |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
155,668 |
|
Indirect Shares
|
6,673 |
|
|
Direct
Value |
$5,222,943 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
162,341 |
|
|
Total
Value |
$5,222,943 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
CV Therapeutics Inc |
CVTX |
SVP, CFO |
2009-04-09 |
67,489 |
2009-04-09 |
6,673 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
Director |
2018-03-09 |
0 |
2009-12-04 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2019-04-30 |
47,686 |
2012-05-29 |
0 |
Premium* |
|
Relypsa Inc |
RLYP |
Director |
2016-09-01 |
0 |
2015-06-04 |
0 |
Premium* |
|
Myriad Genetics Inc |
MYGN |
Director |
2023-06-02 |
40,493 |
2020-05-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2015-05-18 |
4 |
AS |
$130.00 |
$4,430,140 |
D/D |
(34,078) |
41,507 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2015-05-29 |
4 |
AS |
$126.15 |
$199,065 |
D/D |
(1,578) |
35,624 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2015-05-29 |
4 |
D |
$125.57 |
$540,579 |
D/D |
(4,305) |
37,202 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2015-05-18 |
4 |
S |
$124.77 |
$256,905 |
D/D |
(2,059) |
75,585 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2015-06-01 |
4 |
AS |
$124.16 |
$489,811 |
D/D |
(3,945) |
31,679 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2015-05-15 |
4 |
D |
$122.78 |
$211,427 |
D/D |
(1,722) |
77,644 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2015-06-05 |
4 |
AS |
$122.30 |
$201,669 |
D/D |
(1,649) |
28,229 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2015-06-04 |
4 |
D |
$120.46 |
$216,948 |
D/D |
(1,801) |
29,878 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2015-03-02 |
4 |
S |
$107.00 |
$1,658,500 |
D/D |
(15,500) |
68,676 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2015-11-16 |
4 |
AS |
$104.30 |
$2,085,918 |
D/D |
(20,000) |
28,229 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-08-01 |
4 |
AS |
$99.33 |
$397,320 |
D/D |
(4,000) |
42,944 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2018-06-22 |
4 |
AS |
$99.00 |
$990,005 |
D/D |
(10,000) |
51,070 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2019-03-01 |
4 |
D |
$94.76 |
$86,421 |
D/D |
(912) |
62,538 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2019-03-15 |
4 |
D |
$94.53 |
$683,168 |
D/D |
(7,227) |
55,311 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-03-01 |
4 |
AS |
$94.50 |
$472,500 |
D/D |
(5,000) |
25,347 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-02-28 |
4 |
AS |
$94.00 |
$2,820,000 |
D/D |
(30,000) |
30,347 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-03-03 |
4 |
D |
$93.95 |
$214,488 |
D/D |
(2,283) |
23,064 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-03-06 |
4 |
AS |
$93.32 |
$214,916 |
D/D |
(2,303) |
20,761 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-03-15 |
4 |
D |
$92.50 |
$397,843 |
D/D |
(4,301) |
16,460 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2018-06-04 |
4 |
D |
$92.07 |
$157,532 |
D/D |
(1,711) |
61,070 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-03-16 |
4 |
AS |
$91.96 |
$182,908 |
D/D |
(1,989) |
14,471 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-05-15 |
4 |
D |
$91.50 |
$157,563 |
D/D |
(1,722) |
25,104 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-06-02 |
4 |
D |
$90.72 |
$163,387 |
D/D |
(1,801) |
23,303 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-11-09 |
4 |
S |
$90.61 |
$1,812,206 |
D/D |
(20,000) |
23,100 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-06-03 |
4 |
D |
$90.00 |
$162,090 |
D/D |
(1,801) |
48,593 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|